TREATMENT OF HEMATOLOGICAL NEOPLASMS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20150231167A1
SERIAL NO

14421623

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Hematological neoplasms resistant to treatment with an ATP-competitive inhibitor of BCR-ABL are treated by administration of N6-benzyladenosine, N6-benzyladenosine-5′-monophosphate, or pharmaceutically acceptable salts thereof.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
THOMAS JEFFERSON UNIVERSITY1020 WALNUT STREET PHILADELPHIA PA 19107

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Liao, Zhiyong Wynnewood, US 36 27
Nevalainen, Marja Tuuli Gladwyne, US 3 0

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation